Compound 1497
Identifiers
- Canonical SMILES:
CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1cc(C)c(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1
- IUPAC name:
6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]-4-methylpyridine-3-carboxylic acid
- InChi:
InChI=1S/C27H21Cl2N5O4/c1-15-7-23(31-12-21(15)24(35)36)33-13-22(17-5-3-16(11-30)4-6-17)27(14-33)25(37)34(26(38)32(27)2)20-9-18(28)8-19(29)10-20/h3-10,12,22H,13-14H2,1-2H3,(H,35,36)/t22-,27+/m0/s1
- InChiKey:
NYIQRNXFPZZFNO-WXVAWEFUSA-N
External links
![]() 46220963 |
![]() CHEMBL1099103 |
![]() 24673123 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 7.96 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 549.10 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 3.25 | |||
TPSA | 117.84 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5837 | Degarelix | DB06699 | |
0.5302 | ALK-4290 | DB15269 | |
0.5140 | SB-705498 | DB11883 | |
0.5000 | Alatrofloxacin | DB09335 | |
0.4962 | Ivosidenib | DB14568 | |
0.4908 | Ubrogepant | DB15328 | |
0.4862 | MK-3207 | DB12424 | |
0.4839 | Olcegepant | DB04869 | |
0.4744 | XL-888 | DB12981 | |
0.4716 | Acyline | DB11906 | |
0.4690 | BMS-564929 | DB07286 | |
0.4644 | LTX-109 | DB12711 | |
0.4638 | Telinavir | DB12178 | |
0.4624 | Bremelanotide | DB11653 | |
0.4603 | SJ-733 | DB12659 |